MarketWatch » Biotech Industry on Feedspot

Kairos Pharma to sell 1.55 million shares in IPO at $4 each

MarketWatch » Biotech Industry

by

1M ago

Visit website

My employer hires exclusively white managers and promotes people of ‘questionable expertise.’ Is this a good or bad time to jump ship?

MarketWatch » Biotech Industry

by

2M ago

Visit website

AI can save us and the planet — but we might not be smart enough, Roubini says

MarketWatch » Biotech Industry

by

2M ago

Visit website

This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less risk

MarketWatch » Biotech Industry

by

2M ago

Visit website

AbbVie lowers first-quarter guidance after closing acquisition ImmunoGen

MarketWatch » Biotech Industry

by

2M ago

Visit website

Biogen’s stock slides as quarterly results miss expectations amid slow launch of Alzheimer’s treatment

MarketWatch » Biotech Industry

by

2M ago

Visit website

Here’s a new way to consider value for stocks in the S&P 500

MarketWatch » Biotech Industry

by

2M ago

Visit website

This ETF outperforms by stressing corporate culture — but not ESG

MarketWatch » Biotech Industry

by

2M ago

Visit website

Elon Musk says Neuralink has implanted brain chip into a human for the first time

MarketWatch » Biotech Industry

by

2M ago

Visit website

Too much ‘Magnificent Seven’? A revenue-weighted index fund may be the solution.

MarketWatch » Biotech Industry

by

2M ago

Visit website

Follow MarketWatch » Biotech Industry on FeedSpot